These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 33959037)

  • 41. Quantitative assessment of cerebral hemodynamic parameters by QUASAR arterial spin labeling in Alzheimer's disease and cognitively normal Elderly adults at 3-tesla.
    Mak HK; Chan Q; Zhang Z; Petersen ET; Qiu D; Zhang L; Yau KK; Chu LW; Golay X
    J Alzheimers Dis; 2012; 31(1):33-44. PubMed ID: 22504315
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cortical oxygen extraction fraction using quantitative BOLD MRI and cerebral blood flow during vasodilation.
    Le LNN; Wheeler GJ; Holy EN; Donnay CA; Blockley NP; Yee AH; Ng KL; Fan AP
    Front Physiol; 2023; 14():1231793. PubMed ID: 37869717
    [No Abstract]   [Full Text] [Related]  

  • 43. Hemodynamic imaging parameters in brain metastases patients - Agreement between multi-delay ASL and hypercapnic BOLD.
    van Grinsven EE; Guichelaar J; Philippens ME; Siero JC; Bhogal AA
    J Cereb Blood Flow Metab; 2023 Dec; 43(12):2072-2084. PubMed ID: 37632255
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cerebral blood flow and cerebrovascular reactivity correlate with severity of motor symptoms in Parkinson's disease.
    Pelizzari L; Laganà MM; Rossetto F; Bergsland N; Galli M; Baselli G; Clerici M; Nemni R; Baglio F
    Ther Adv Neurol Disord; 2019; 12():1756286419838354. PubMed ID: 30923574
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Silent infarction in sickle cell disease is associated with brain volume loss in excess of infarct volume.
    Jones RS; Donahue MJ; Davis LT; Pruthi S; Waddle SL; Custer C; Patel NJ; DeBaun MR; Kassim AA; Rodeghier M; Jordan LC
    Front Neurol; 2023; 14():1112865. PubMed ID: 37064181
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparing accuracy and reproducibility of sequential and Hadamard-encoded multidelay pseudocontinuous arterial spin labeling for measuring cerebral blood flow and arterial transit time in healthy subjects: A simulation and in vivo study.
    Guo J; Holdsworth SJ; Fan AP; Lebel MR; Zun Z; Shankaranarayanan A; Zaharchuk G
    J Magn Reson Imaging; 2018 Apr; 47(4):1119-1132. PubMed ID: 28792653
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Staging Hemodynamic Failure With Blood Oxygen-Level-Dependent Functional Magnetic Resonance Imaging Cerebrovascular Reactivity: A Comparison Versus Gold Standard (
    Fierstra J; van Niftrik C; Warnock G; Wegener S; Piccirelli M; Pangalu A; Esposito G; Valavanis A; Buck A; Luft A; Bozinov O; Regli L
    Stroke; 2018 Mar; 49(3):621-629. PubMed ID: 29371433
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Normalization of cerebral hemodynamics after hematopoietic stem cell transplant in children with sickle cell disease.
    Hulbert ML; Fields ME; Guilliams KP; Bijlani P; Shenoy S; Fellah S; Towerman AS; Binkley MM; McKinstry RC; Shimony JS; Chen Y; Eldeniz C; Ragan DK; Vo K; An H; Lee JM; Ford AL
    Blood; 2023 Jan; 141(4):335-344. PubMed ID: 36040484
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Assessment of cerebral perfusion in moyamoya disease with dynamic pseudo-continuous arterial spin labeling using a variable repetition time scheme with optimized background suppression.
    Togao O; Obara M; Yamashita K; Kikuchi K; Arimura K; Nishimura A; Nakamizo A; Wada T; Tokunaga C; Mikayama R; Yamashita Y; Hamano H; Van Cauteren M; Ishigami K; Baba S
    Neuroradiology; 2023 Mar; 65(3):529-538. PubMed ID: 36434310
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evaluation of Cerebrovascular Reactivity and Vessel Wall Imaging in Patients With Prior COVID-19: A Prospective Case-Control MRI Study.
    Callen AL; Tanabe J; Thaker AA; Pollard R; Sauer B; Jones W; Pattee J; Steach B; Timpone VM
    AJR Am J Roentgenol; 2023 Feb; 220(2):257-264. PubMed ID: 36000667
    [No Abstract]   [Full Text] [Related]  

  • 51. Relationship between vasodilatation and cerebral blood flow increase in impaired hemodynamics: a PET study with the acetazolamide test in cerebrovascular disease.
    Okazawa H; Yamauchi H; Toyoda H; Sugimoto K; Fujibayashi Y; Yonekura Y
    J Nucl Med; 2003 Dec; 44(12):1875-83. PubMed ID: 14660711
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cerebral perfusion characteristics show differences in younger versus older children with sickle cell anaemia: Results from a multiple-inflow-time arterial spin labelling study.
    Kawadler JM; Hales PW; Barker S; Cox TCS; Kirkham FJ; Clark CA
    NMR Biomed; 2018 Jun; 31(6):e3915. PubMed ID: 29601112
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Multi-parametric analysis reveals metabolic and vascular effects driving differences in BOLD-based cerebrovascular reactivity associated with a history of sport concussion.
    Champagne AA; Coverdale NS; Germuska M; Cook DJ
    Brain Inj; 2019; 33(11):1479-1489. PubMed ID: 31354054
    [No Abstract]   [Full Text] [Related]  

  • 54. The spatial coefficient of variation in arterial spin labeling cerebral blood flow images.
    Mutsaerts HJ; Petr J; Václavů L; van Dalen JW; Robertson AD; Caan MW; Masellis M; Nederveen AJ; Richard E; MacIntosh BJ
    J Cereb Blood Flow Metab; 2017 Sep; 37(9):3184-3192. PubMed ID: 28058975
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The effect of post-labeling delay on cerebral blood flow is influenced by age and sex: a study based on arterial spin-labeling magnetic resonance imaging.
    Hu Y; Zhang K; Liu R
    Quant Imaging Med Surg; 2024 Jul; 14(7):4388-4402. PubMed ID: 39022245
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Assessment of cerebrovascular function in patients with sickle cell disease using transfer function analysis.
    Sayin ES; Sobczyk O; Poublanc J; Mikulis DJ; Fisher JA; Kuo KHM; Duffin J
    Physiol Rep; 2022 Oct; 10(19):e15472. PubMed ID: 36200271
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Assessing Cerebrovascular Resistance in Patients With Sickle Cell Disease.
    Sayin ES; Sobczyk O; Poublanc J; Mikulis DJ; Fisher JA; Kuo KHM; Duffin J
    Front Physiol; 2022; 13():847969. PubMed ID: 35422710
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Detectability of white matter cerebral blood flow using arterial spin labeling MRI in patients with sickle cell disease: Relevance of flow territory, bolus arrival time, and hematocrit.
    Richerson WT; Aumann M; Song AK; Eisma JJ; Davis S; Milner L; Garza M; Taylor Davis L; Martin D; Jordan LC; Donahue MJ
    J Cereb Blood Flow Metab; 2024 Sep; ():271678X241270283. PubMed ID: 39253827
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Incorporating a parenchymal thermal diffusion cerebral blood flow probe in bedside assessment of cerebral autoregulation and vasoreactivity in patients with severe traumatic brain injury.
    Rosenthal G; Sanchez-Mejia RO; Phan N; Hemphill JC; Martin C; Manley GT
    J Neurosurg; 2011 Jan; 114(1):62-70. PubMed ID: 20707619
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cerebrovascular reserve in moyamoya disease: relation to cerebral blood flow, capillary dysfunction, oxygenation, and energy metabolism.
    Svedung Wettervik T; Fahlström M; Wikström J; Lewén A; Enblad P
    Front Neurol; 2023; 14():1190309. PubMed ID: 37545732
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.